JP2007502785A5 - - Google Patents

Download PDF

Info

Publication number
JP2007502785A5
JP2007502785A5 JP2006523530A JP2006523530A JP2007502785A5 JP 2007502785 A5 JP2007502785 A5 JP 2007502785A5 JP 2006523530 A JP2006523530 A JP 2006523530A JP 2006523530 A JP2006523530 A JP 2006523530A JP 2007502785 A5 JP2007502785 A5 JP 2007502785A5
Authority
JP
Japan
Prior art keywords
phenyl
propyl
methyl
chloro
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006523530A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007502785A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2004/000547 external-priority patent/WO2005018676A1/en
Publication of JP2007502785A publication Critical patent/JP2007502785A/ja
Publication of JP2007502785A5 publication Critical patent/JP2007502785A5/ja
Withdrawn legal-status Critical Current

Links

JP2006523530A 2003-08-21 2004-08-18 うつ病の治療のためのセロトニン再取り込み阻害剤およびグリシントランスポーター1型阻害剤の併用 Withdrawn JP2007502785A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49673803P 2003-08-21 2003-08-21
DKPA200301198 2003-08-21
PCT/DK2004/000547 WO2005018676A1 (en) 2003-08-21 2004-08-18 The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression

Publications (2)

Publication Number Publication Date
JP2007502785A JP2007502785A (ja) 2007-02-15
JP2007502785A5 true JP2007502785A5 (cg-RX-API-DMAC7.html) 2007-09-20

Family

ID=34219531

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006523530A Withdrawn JP2007502785A (ja) 2003-08-21 2004-08-18 うつ病の治療のためのセロトニン再取り込み阻害剤およびグリシントランスポーター1型阻害剤の併用

Country Status (12)

Country Link
US (1) US20060223857A1 (cg-RX-API-DMAC7.html)
EP (1) EP1660130A1 (cg-RX-API-DMAC7.html)
JP (1) JP2007502785A (cg-RX-API-DMAC7.html)
KR (1) KR20060066729A (cg-RX-API-DMAC7.html)
CN (1) CN1867358A (cg-RX-API-DMAC7.html)
AU (1) AU2004266057A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0413587A (cg-RX-API-DMAC7.html)
CA (1) CA2536275A1 (cg-RX-API-DMAC7.html)
IS (1) IS8277A (cg-RX-API-DMAC7.html)
MX (1) MXPA06002002A (cg-RX-API-DMAC7.html)
NO (1) NO20061167L (cg-RX-API-DMAC7.html)
WO (1) WO2005018676A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1458689B1 (en) * 2001-12-20 2007-04-11 H. Lundbeck A/S Aryloxyphenyl and arylsulfanylphenyl derivatives
US8604080B2 (en) * 2007-02-14 2013-12-10 W. Louis Cleveland High dose glycine as a treatment for obsessive-compulsive disorder and obsessive compulsive spectrum disorders
CN101338337B (zh) * 2007-07-04 2011-11-02 北京华安佛医药研究中心有限公司 多态性位点基因型预测抑郁症及药效的用途、方法和试剂盒
EP2380595A1 (en) 2010-04-19 2011-10-26 Nlife Therapeutics S.L. Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
CN102949364A (zh) * 2011-08-30 2013-03-06 天津药物研究院 一种含有效成分盐酸维拉佐酮的缓释片
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361957B1 (en) * 1999-08-03 2002-03-26 Glytech, Inc. Assay for D-serine transport antagonist and use for treating psychosis
PT871440E (pt) * 1995-12-07 2006-07-31 Daniel C Javitt Tratamento de sintomas negativos e cognitivos de esquizofrenia com antagonistas da captacao de glicina
AU730789B2 (en) * 1996-05-31 2001-03-15 Nps Pharmaceuticals, Inc. Pharmaceutical for treatment of neurological and neuropsychiatric disorders
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent
GB2336534A (en) * 1998-04-24 1999-10-27 Alec James Coppen Anti-depressant - Folic Acid Combination
DOP2001000189A (es) * 2000-06-30 2002-03-30 Pfizer Prod Inc Benzofenonas y sulfonas como inhibidores de la captación de glicina
HUP0302778A3 (en) * 2000-07-21 2005-02-28 Lundbeck & Co As H Novel compounds and their use as glycine transport inhibitors
EP1458689B1 (en) * 2001-12-20 2007-04-11 H. Lundbeck A/S Aryloxyphenyl and arylsulfanylphenyl derivatives
AU2003240434A1 (en) * 2002-06-20 2004-01-06 H. Lundbeck A/S Combination therapy wherein a serotinin reuptake inhibitor is used
UA80055C2 (en) * 2003-05-27 2007-08-10 Forest Laboratories Combination of nmda-receptor antagonist and selective inhibitor of serotonin reuptake for a depression and other pscihiatric disorders treatment

Similar Documents

Publication Publication Date Title
US8754119B2 (en) Use of rotigotine for the treatment of depression
RU2445973C2 (ru) Способ лечения глубокой депрессии у человека
JP2008536946A (ja) うつ病の処置または予防のための新規の治療的組み合わせ
KR20090029200A (ko) 우울증 질환에 대한 치료
JP2008538741A (ja) 鬱病の治療用及び/又は予防用の医薬組成物
JP2011523949A5 (cg-RX-API-DMAC7.html)
BRPI0610037A2 (pt) derivados de dihidrobenzofurano e uso dos mesmos
KR20040030609A (ko) 경상이성체성 순수 에스시탈로프람의 용도
JP2007513052A5 (cg-RX-API-DMAC7.html)
JP2006522030A5 (cg-RX-API-DMAC7.html)
Khawaja et al. Cardiovascular effects of selective serotonin reuptake inhibitors and other novel antidepressants
CA2488138A1 (en) Treatment for depression and anxiety by the combination of a pde iv inhibitor and an antidepressant or an anxiolytic agent
PE20040924A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
JP2007505156A5 (cg-RX-API-DMAC7.html)
HRP20120713T1 (hr) Kombinacija analeptičkog modafinila i antidepresiva za liječenje depresije
GEP20074225B (en) Use of carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
JP2007513896A5 (cg-RX-API-DMAC7.html)
MXPA06002002A (es) La combinacion de un inhibidor de reabsorcion de serotonina y un inhibidor de transportador de glicina tipo 1 para el tratamiento de depresion.
FR2912057A1 (fr) Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
AU6378199A (en) A new composition
US20060217394A1 (en) Treatment of anhedonia
AU2007283530A1 (en) Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination
EP1928448B1 (fr) ASSOCIATION D'AGONISTE AUX RECEPTEURS ß3 ET D'INHIBITEURS DE LA RECAPTURE DE MONOAMINES, COMPOSITION PHARMACEUTIQUE LA CONTENANT ET SON UTILISATION EN THERAPEUTIQUE
AU6377999A (en) A new composition
Hamon C. 15.02 Pharmacological profile of antidepressants: a likely basis for their efficacy and side effects?